Nika Pharmaceuticals NIKA
OTC NIKA
$0.41 +0.00 (+0.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

Nika Pharmaceuticals, Inc (NIKA) Cash & Equivalents (2021 - 2023)

Updated

Nika Pharmaceuticals (NIKA) reported Cash & Equivalents of $864.00 for Q4 2023, unchanged from $864.00 a year earlier and down 92.1% from the prior quarter.

Analysis

Nika Pharmaceuticals, Inc (NIKA) Cash & Equivalents (2021 - 2023) Analysis & Trends

Dating back to Q1 2021, Nika Pharmaceuticals' Cash & Equivalents record includes 11 quarters.

  • By year, Cash & Equivalents came in at $864.00 in FY2022 (+116.5%) and $399.00 in FY2021.
  • Five-year quarterly Cash & Equivalents spans a low of $83.00 in Q1 2022 and a high of $11,053 in Q2 2023.
  • Year over year, Cash & Equivalents gained in four of the last six quarters, with growth averaging 60.2%.
  • Per Business Quant data, the three quarters before Q4 2023 came in at $10,910 (Q3 2023), $11,053 (Q2 2023) and $4,459 (Q1 2023).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 864.00
Sep 30, 2023 10,910.00
Jun 30, 2023 11,053.00
Mar 31, 2023 4,459.00
Dec 31, 2022 864.00
Sep 30, 2022 3,914.00
Jun 30, 2022 8,545.00
Mar 31, 2022 83.00
Dec 31, 2021 399.00
Sep 30, 2021 1,699.00
Mar 31, 2021 1,357.00
API Access

Nika Pharmaceuticals, Inc Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NIKA&period=max&api_key=YOUR_API_KEY